In a patient anesthetized with sevoflurane, target‑controlled infusion remifentanil, and rocuronium as a muscle relaxant, how can I achieve a smooth extubation using sugammadex while preventing bucking?

Smooth Extubation Strategy with Sugammadex to Prevent Bucking

To achieve smooth extubation and prevent bucking in your patient on sevoflurane, TCI remifentanil, and rocuronium, maintain deep anesthesia until the moment of extubation by continuing remifentanil infusion, then administer appropriately dosed sugammadex based on TOF monitoring, and only extubate when the patient is awake enough to follow commands while still under the suppressive effects of remifentanil.

Core Strategy: Deep Anesthesia Until Extubation

The key to preventing bucking is maintaining adequate depth of anesthesia during the reversal and emergence period. Your remifentanil TCI is the critical tool here 1.

Step-by-Step Protocol

1. Timing of Sugammadex Administration

Before giving sugammadex, assess your neuromuscular blockade depth using TOF monitoring 2:

• If TOF count = 4 responses: Give 1.0 mg/kg sugammadex (reversal in <5 minutes) 2
• If TOF count = 2 responses: Give 2.0 mg/kg sugammadex (reversal in <5 minutes) 2
• If deep block (PTC 1-2): Give 4.0 mg/kg sugammadex (reversal in 3-5 minutes) 2

The sugammadex dose is based on ideal body weight, not actual body weight 2.

2. Remifentanil Management During Emergence

This is your primary tool to prevent bucking. Follow this sequence 1:

• Continue your remifentanil TCI at the current rate through the end of surgery
• Do NOT stop remifentanil when you give sugammadex
• Discontinue sevoflurane but maintain remifentanil infusion
• Continue positive pressure ventilation
• Wait for the patient to open eyes to command while still on remifentanil
• Only when spontaneous ventilation is adequate AND patient responds to commands, then discontinue remifentanil and extubate simultaneously

3. Critical Timing Considerations

The interaction between sevoflurane and rocuronium means your neuromuscular blockade may be deeper than expected 3, 4. However, sugammadex maintains its rapid reversal efficacy even under sevoflurane anesthesia:

• Recovery to TOF ratio ≥0.9 occurs in 1.7-3.3 minutes with appropriate sugammadex dosing under sevoflurane 3
• This is comparable to propofol-based anesthesia 4, 5

4. Monitoring Requirements

• Continue TOF monitoring after sugammadex administration to detect potential recurarization 2
• Monitor for adequate spontaneous ventilation (rate 10-25/min, satisfactory capnogram) 6
• Ensure TOF ratio >0.9 before extubation 6

Common Pitfalls to Avoid

Underdosing Sugammadex: The most common error is giving insufficient sugammadex for the depth of block. Inadequate dosing causes recurarization and can lead to bucking as partial paralysis returns 2. Always assess TOF/PTC before dosing.

Stopping Remifentanil Too Early: If you discontinue remifentanil before the patient is ready to extubate, airway reflexes return while the tube is still in place, causing violent bucking. The remifentanil should suppress cough reflexes until the moment of tube removal 1.

Rushing Emergence: Do not stimulate the patient or rush extubation. The effective remifentanil concentration to prevent coughing during emergence from sevoflurane is approximately 1.7 ng/mL 7. Let the patient emerge naturally to eye-opening while maintaining this suppression.

Ignoring Sevoflurane Potentiation: Sevoflurane prolongs rocuronium's effect, so your block may be deeper than the time since last dose suggests 3. Always use objective monitoring rather than estimating.

Special Considerations

Elderly Patients: Sugammadex efficacy is decreased in elderly patients, particularly for deep blockade reversal 2. Consider using the higher end of dosing ranges.

Renal Impairment: If creatinine clearance <30 mL/min, sugammadex efficacy is reduced 2. Use higher doses and monitor more carefully for recurarization.

Post-Extubation Monitoring: After extubation, there is risk of respiratory depression from residual remifentanil 1. Close monitoring is essential until fully recovered. Remember remifentanil has no long-term analgesic effects and can be antagonized with naloxone if needed 1.

This approach leverages the rapid, reliable reversal of sugammadex while using remifentanil's unique pharmacokinetics to maintain airway tolerance until the precise moment of extubation, preventing the bucking that occurs when airway reflexes return prematurely.